StockData
BioCardia, Inc. logo

BioCardia, Inc. (BCDA) stock

BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.79−0.00 (-0.24%)

Close on Nov 17, 2026Market cap $11.93MP/E –Yield –

BioCardia price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

BioCardia's price to sales ratio was 249.1× on Apr 30, 2025, against 19.4× a year earlier. Over the last 3 years it ranged from 11.6× to 499.9×, with a median of 274.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 2025249.1×+110.2
2024Dec 31, 2024138.9×−236.6
2023Dec 29, 2023375.5×−46.6
2022Dec 30, 2022422.1×−77.8
2021Dec 31, 2021499.9×+18.1
2020Jul 31, 2020481.8×–

More BioCardia figures

See a number that looks wrong?